Showing results (81-90 of 141) with videos related to
Sort By:
Pageof 15
Annals of Gastroenterology|March 7, 2019
Presence of pseudopolyps in ulcerative colitis is associated with a higher risk for treatment escalationDimitrios S Politis, Konstantinos Papamichael, Konstantinos H Katsanos, et al.Journal of Clinical Gastroenterology|July 13, 2018
Effect of Consent and Educational Adjuncts to Consent on Patient Perceptions About ColonoscopyDavid I Fudman, Konstantinos Papamichael, Lilach Roemi, et al.Alimentary Pharmacology & Therapeutics|October 23, 2025
Maternal and Perinatal Outcomes in Pregnant Women With Comorbid Inflammatory Bowel Disease and Chronic Liver DiseaseJessica D Lee, Konstantinos Papamichael, Lauren T Grinspan, et al.Clinical and Translational Gastroenterology|December 9, 2016
Rapid Test for Infliximab Drug Concentration Allows Immediate Dose AdaptationThomas Van Stappen, Lize Bollen, Niels Vande Casteele, et al.Digestive Diseases and Sciences|July 16, 2010
Antiglycan antibodies in Greek patients with inflammatory bowel diseaseIoannis E Koutroubakis, Dimitrios Drygiannakis, Alexandra Tsirogianni, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 3, 2017
Improved Long-term Outcomes of Patients With Inflammatory Bowel Disease Receiving Proactive Compared With Reactive Monitoring of Serum Concentrations of InfliximabKonstantinos Papamichael, Karen A Chachu, Ravy K Vajravelu, et al.Expert Review of Clinical Pharmacology|February 11, 2026
Therapeutic drug monitoring for de-escalating anti-tumor necrosis factor therapy in patients with inflammatory bowel diseaseAjay Gade, Alessandra Saraga, Alfonso Elosua, et al.Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|October 24, 2022
Patients with coronavirus disease 2019 characterized by dysregulated levels of membrane and soluble cluster of differentiation 48Hadas Pahima, Ilan Zaffran, Eli Ben-Chetrit, et al.Journal of Crohn'S & Colitis|January 29, 2019
Proactive Therapeutic Drug Monitoring of Adalimumab Is Associated With Better Long-term Outcomes Compared With Standard of Care in Patients With Inflammatory Bowel DiseaseKonstantinos Papamichael, Anna Juncadella, Danny Wong, et al.Immunological Investigations|March 26, 2014
Cytokines and insulin resistance after zoledronic acid-induced acute phase responseGeorgia Kassi, Konstantinos Papamichael, Garyfallia Papaioannou, et al.Pageof 15